ÂÜÀòÂÒÂ×

Dr. Amirana has a unique combination of operating and venture capital experience in both medtech and pharma/biotech and has cross fertilized various disciplines throughout his career. He has served as an operator, board member and investor since 2005 and prior to that was in operating roles. He currently serves as CEO of LuxMed Systems. He most recently managed the life sciences portfolio at Allied Minds, an investment / IP commercialization vehicle which is publicly listed on the London Stock Exchange. Prior to that he was a Partner at Oxford BioScience Partners where he sourced deals, led investments and served on numerous boards. His investing and operating experience covers medical devices, drug discovery and healthcare IT/data analytics. Omar has served on over 20 boards and has participated in over $1billion of capital raises and transactions. Prior to his ~14 years in venture capital, he served in Silicon Valley for 11 years where he co-founded or held varying operating roles in 4 life sciences startups (3 went public on NASDAQ). He participated in an IPO roadshow for an electrophysiology company he co-founded, Cardima, which was a spin-off of Target Therapeutics and was funded by Kleiner Perkins and NEA. After Silicon Valley, he served as VP of Business Development for the electrophysiology business unit at St Jude Medical (STJ; now Abbott) in Minneapolis, MN while managing an advanced development group of ~20 engineers. Omar has worked with numerous investors, Scientific Advisory Boards, inventors and investigators. He is an inventor on numerous issued patents and is passionate about the intersection of life sciences and technology. Omar loves the beach, basketball, golf, paddle ball, the outdoors, travel and spending precious time with his wife, daughters, family and dog.